Agilent Technologies and Temasek Polytechnic Collaborate in Product Safety Testing
Agilent Technologies (California, USA) and Temasek Polytechnic (Singapore) have announced the opening of a new laboratory to provide support to small and mid-size companies (SMEs) involved in the manufacture or distribution of traditional Chinese medicine and food products.
Agilent Technologies (California, USA) and Temasek Polytechnic (Singapore) have announced the opening of a new laboratory to provide support to small and mid-size companies (SMEs) involved in the manufacture or distribution of traditional Chinese medicine and food products.
The laboratory is located in the School of Applied Sciences at Temasek Polytechnic. Scientists based at the facility will test products at various stages of development and production to ensure high quality control. The collaboration forms part of the Agilent Partner Labs network in the South Asia-Pacific and Korea region.
Dr Lee Chee Wee, director of the School of Applied Science at Temasek Polytechnic, said: "Temasek Polytechnic has a strong track record in helping Singapore businesses, especially SMEs in the area of analytical science. Through our interactions with SMEs, we know that they want capabilities in high-value, low-volume testing services at an internationally established laboratory."
Tan Mei Mei, business director of the South Asia-Pacific region Chemical Analysis Group of Agilent, said: "Agilent has a long history of developing analytical tools and methods used by governments, commercial enterprises, and private labs around the globe for the detection, identification, and confirmation of biological and chemical agents and toxic industrial compounds in various industries.” She added: “Manufacturers and distributors of products used in traditional Chinese medicine, for example, need to ensure safety, quality, and authenticity of their ingredients and must conform to increasingly stringent standards around the world and in Singapore."
For more information please visit:
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
